DEMECLOCYCLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Demeclocycline, and when can generic versions of Demeclocycline launch?
Demeclocycline is a drug marketed by Amneal Pharm, Barr, Epic Pharma Llc, and Impax Labs. and is included in five NDAs.
The generic ingredient in DEMECLOCYCLINE is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Demeclocycline
A generic version of DEMECLOCYCLINE was approved as demeclocycline hydrochloride by AMNEAL PHARM on February 27th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEMECLOCYCLINE?
- What are the global sales for DEMECLOCYCLINE?
- What is Average Wholesale Price for DEMECLOCYCLINE?
Summary for DEMECLOCYCLINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 5 |
| Drug Prices: | Drug price information for DEMECLOCYCLINE |
| DailyMed Link: | DEMECLOCYCLINE at DailyMed |


